Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Effects of BMPr and ROCK inhibition in a 3D organotypic human palate fusion model

On this page:

  • Overview
Cleft palate is one of the most common birth defects in the United States, effecting an estimated 1 in 1700 births. Palatogenesis is a multistage process that includes fusion, the dissolution of the palatal shelves’ medial edge epithelium (MEE) allowing the mesenchymal cores to merge. Fusion involves numerous biochemical and genetic regulatory pathways including Bone Morphogenetic Proteins (BMPs) and Rho-activated kinase (ROCK). ROCK mediates cellular processes including contraction, adhesion, migration, and apoptosis, on which dissolution of the MEE is partly dependent. We used a 3D heterotypic human palate organoid model to evaluate the effects of Y-27632, a ROCK inhibitor, and K02288, a BMP-receptor inhibitor, on organoid fusion and cytotoxicity. We hypothesized that these antagonists would inhibit organoid fusion when compared to controls. Spheroids were generated from umbilical-derived human mesenchymal stem cells (hMSCs) and human umbilical vascular endothelial cells (HUVECs) by seeding onto agarose microwells at a ratio of 2:1 respectively and culturing in osteogenic differentiation medium. After seven days of culture, spheroids were differentiated as confirmed by alkaline phosphatase and coated with human primary epithelial keratinocytes (hPEKs), completing the organoid model. Organoids were cultured for 3 days with 1µM, 5µM, and 10µM concentrations of Y-27632 or K02288. At 5µM and 10 µM, K02288 inhibited fusion (p< 0.0013 and p< 0.0005, respectively) and increased ATP content (p<0.05). Y-27632 did not inhibit fusion at any concentration, but increased ATP content with increasing concentration (trend, p=0.0508) and at higher concentrations, often resulted in apparent proliferation and migration of hPEKs. Neither compound exhibited cytotoxic effects. These results demonstrate the importance of BMP signaling in our model. Inhibition of the ROCK pathway appears to have effects other than disruption of fusion in this model. Further research is needed to determine the action of ROCK signaling in our model. This abstract does not necessarily reflect EPA policy.

Impact/Purpose

The contribution of teratogenic chemicals to cleft palate in humans is difficult to determine and has been limited to epidemiological studies, for which data is hard to obtain. Developing in vitro models using human stem cells allows us to study the contribution of chemicals on cleft palate in the human and allows more efficient testing of chemicals in medium throughput assays. The current study describes an improved organotypic model for human palate fusion and testing of the model with signaling pathway inhibitors.

Citation

Fitzpatrick, H. AND C. Wolf. Effects of BMPr and ROCK inhibition in a 3D organotypic human palate fusion model. Birth Defects Research and Prevention Annual meeting, Vancouver, British Columbia, CANADA, June 25 - 29, 2022.
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on November 01, 2022
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.